ABSTRACT
INTRODUCTION
In mammalian cells, many agonists stimulate concurrent activation of phospholipase C (PLC), phospholipase A 2 (PLA 2 ) phosphatidylinositol 3-kinase and phospholipase D (PLD)-catalysed hydrolysis of phosphatidylcholine (PtdCho) to yield the novel lipid messenger phosphatidic acid (PA) [1] [2] [3] . In human cells, PLD1b and PLD2a are the most commonly expressed variants; both contain the characteristic HKD catalytic triad (the 'PLD domain') characteristic of members of the PLDsuperfamily and have similar domain structures [1, 2, 4] . The role of ADP-ribosylation factors (Arfs), the Rho-family of proteins, protein kinase C (PKC) and polyphosphoinositides in regulating phospholipase D activity and localisation is now largely understood [1, 2, [5] [6] [7] .
PLD-catalysed PtdCho hydrolysis plays a regulatory role in important processes such as the oxidative burst in neutrophils [8, 9] , secretion [10] [11] [12] , mitogenesis [13, 14] and cellular shape change and adhesion [15] [16] [17] .
Changes in the dynamics of the actin cytoskeleton may represent the common target for PLD signalling for at least some of these processes [15] . We have recently shown a functional link between role and regulation of PLD1b through association with Factin during antigen-induced secretion in RBL-2H3 cells [17] .
Apoptosis is a highly regulated pathway for cellular execution, initiated by changes in the balance of pro-mitogenic/differentiation signals versus pro-death signals [3, 18, 19] that is characterised by membrane blebbing, phosphatidylserine exposure, cytosolic shrinkage, mitochondrial and nuclear disruption [18, 19] . Apoptotic cell death is implemented following auto-activation of a class of cysteine proteases (caspases), which specifically cleave protein targets containing appropriate aspartate residue within consensus motifs [19, 20] . Ligation of cell-surface death receptors leads to recruitment of adaptor proteins and subsequent activation of caspase-8 that converts inactive caspases-3 and -7 to the active forms, which execute the apoptotic program [18] [19] [20] [21] [22] . Known caspase substrates include cell adhesion molecules (e.g. Cadherins), cytoskeletal proteins (e.g. actin and gelsolin), nuclear proteins (lamins), cell-cycle proteins (cyclin A/E), DNA metabolising enzymes (PARP), transcription factors (NF-kB) and signal transduction proteins including receptors, adaptors, kinases, phosphatases and PLA 2 [21, 22] .
In some cells phosphatidylcholine hydrolysis has been reported to increase during apoptosis [23] [24] [25] , whereas in others PLD activity has been reported to decrease [26] [27] [28] . Furthermore, inhibiting PLD activity can initiate apoptosis [29, 30] with over-expression of PLD1 or PLD2 protecting various cancerous cells from apoptosis [31] [32] [33] [34] , possibly via mechanisms that stabilises p53 via activation of mToR [35, 36] and/or Raf1 or Ral [33] . Thus PLD-based signalling is most likely to be prosurvival and anti-apoptotic [1] [2] [3] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . It is possible that PLD represents a legitimate target for the apoptotic machinery to enable plasma membrane remodelling [2] and necessary disruption of the cytoskeleton. Recently, PLD1 signalling has been shown to be anti-apoptotic in calphostin-c treated smooth muscle cells and inhibition of PLD activity by calphostin-c promoted inhibition of microtubule reorganisation [37] . Here we show that human PLD1b and PLD2a contain functional caspase-3 cleavage sites and identify the critical aspartate residues within PLD1b that affect its activation by phorbol esters and attenuate phosphatidylcholine hydrolysis during apoptosis.
MATERIAL AND METHODS

Bioinformatic analysis of phospholipase sequences.
Sequences for human PLD1 (accession number Q13393-2) and PLD2 (accession number O14939), rodent phospholipases D, phopholipase C and phospholipase A2
were analysed using the Predictor of Protease Specificity (PoPS) web-based bioinformatics tool from Monash University (http://pops.csse.monash.edu.au/). PoPS provides an arithmetic score for detected sites based on the consensus sequences for the selected protease. Five residues are used by the program to score a caspase-3 site within a sequence; these are the 4 residues N-terminal of the cleaved peptide bond (S1-S4) and the first C-terminal residue (S1'). An ideal caspase site would score 25 and weak sites can be filtered from the report using a selected threshold, which was specified at 15 in this study. Results from the PoPS were compared to motif searching within the phospholipase D sequences using 4 residue caspase sites with the consensus sequence of DXXD or D/E, D/E, X, D [20] .
Generation of vectors expressing GFP-PLD mutatants
The open readings frames (ORF) for human PLD1b or PLD2a were cloned in to pcDNA3.1 with an N-terminal GFP tag. Regions from PLD1b or PLD2a were subcloned in to pBluescript using convenient restriction sites and specified aspartate codons changed to alanine by site-directed PCR mutagenesis. The sub-cloned fragments were re-inserted in to the appropriate human PLD ORF in pcDNA3.1. The presence of the mutation within the reconstructed ORF was confirmed by sequencing. caspase-3 (Biomol) in assay buffer (50mM HEPES pH7.4, 100mM NaCl, 0.1% CHAPS, 1mM EDTA, 10% glycerol, 10mM DTT). The competitive inhibitor Acetyl-DDVD-Cho (Pharmingen) was incubated with caspase for 15 minutes prior to mixing with substrates. Proteins were separated by SDS-PAGE (4-12% Tris-glycine gels) and stained with coomassie blue dye. Dried gels were exposed to a storage phosphor screen (Molecular Probes) for 90 minutes before visualisation and quantification of radioactivity (Total-Lab v1). Radioactivity per band was plotted as a percentage of total radioactivity per lane (units). Recombinant PLD1b was produced as described [6, 17] , digested with caspase 3 (as above) and fragments identified by western blotting using the specified antibodies. 
Digestion of in vitro-produced
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HEK-293 cells, grown in
RESULTS
Searches of the protein sequences of human PLD1b and PLD2a with two consensus motifs for caspase 3 cleavage (DXXD or D/E, D/E, X, D) [20] identified several putative sites. The Predictor of Protease Specificity (PoPS) web-based bioinformatics tool provided quantitative scores for the putative caspase cleavage sites within PLD sequences. Within PoPS, caspase 3 sites are defined using four residues N-terminal (S4-S1) and one residue C-terminal (S1') to the cleaved peptide bond to give a maximum achievable score of 25. PoPS analysis identified 3 putative caspase-3 sites (with scores above 15) in the protein sequence of human PLD1b and 2 putative sites in human PLD2a ( Figure 1A ). All of these sites had been identified using the consensus sequence approach.
In human PLD1b, two of the putative caspase sites are located in the 'loop region' at DDVD 549 S and DFID 631 R between the PLD domains ( Figure 1B ). The remaining caspase 3 site in the N-terminus of PLD1b at EEVD 41 Y, is known to be the region of PKC interaction and phosphorylation sites ( Figure 1B ) [17] . Two highscoring putative caspase-3 sites were also identified in the N-terminus of human PLD2a ( Figure 1A ) at DELD 16 S and DEVD 28 T. Of the 3 caspase sites identified in human PLD1b, DFID 669 R is conserved in the rat, but not the mouse, PLD1 sequence.
Of the 2 caspase-3 sites found in human PLD2a, DEVD 28 T is conserved within the mouse but not rat PLD2 sequences. Analysis of the sequences of phospholipases C () and various phospholipase A2 variants demonstrated that the occurrence of these putative caspase 3 sites is specific to phospholipases D (results not shown).
To determine if PLD1b was a caspase-3 substrate, purified recombinant and catalytically active [6, 17] GST-PLD1b (1g) was incubated with purified Figure 2b shows quantification of radioactivity within the 148kDa parent GFPhPLD1b (wild-type and mutants) band following incubation with caspase-3 from 3 separate experiments. As a control human GFP-hPLD2a (134kDa) was also expressed using in vitro coupled transcription and translation. Mutation of D 16 , but not D 28 , to alanine renders human PLD2a caspase-3 insensitive (Fig. 2C and 2D ). Figure 3A shows that approximately half of the in vitro produced GFP-PLD1b protein (at 148kDa) is degraded by caspase-3 within 10 minutes with a concomitant increase in radioactivity in the 70-80kDa fragment (F1). Degradation of GFP-PLD1b is dependent on caspase-3 concentration with near maximal levels of degradation occurring at 15-20nM caspase 3 (Fig. 3B) .
GFP, GFP-PLD1b or GFP-PLD1b D545A and GFP-PLD1b D631A were successfully expressed by transient transfection of human embryonic kidney cells (HEK-293) as determined by con-focal microscopy. Figure 4A shows that GFP is more weakly expressed than wild type PLD1b or the PLD1b mutants. Phorbol esterstimulated PLD activation was measured in HEK 293 cells expressing GFP alone.
The results in figure 4B show that increasing concentrations of phorbol ester result in a 4-fold increase in PLD activity as determined by formation of phosphatidylbutanol.
Transfection of HEK-293 with GFP-PLD1b wt or PLD1b mutants resulted in an approximate 3-fold increase in basal activity that was statistically significant.
However, only wild type-GFP-PLD1b and GFP-PLD1b D545A showed phorbol ester sensitive increases in PLD activity following transfection, mutation of D 631 to alanine rendered this mutant insensitive to subsequent phorbol ester mediated stimulation.
HEK-293 cells expressing wild-type GFP-PLD1b were initiated in to apoptosis by UV-light treatment and phorbol ester-stimulated phosphatidylcholine hydrolysis was measured over 24 hours. During this period there was a 4-fold increase in caspase activity (results not shown) and at 24 hours the cells showed a significant amount of apoptotic phenotypes including membrane blebbing and nuclear condensation and fragmentation (results not shown). In cells expressing wild-type PLD1b, PMA-stimulated phosphatidylcholine hydrolysis initially declined after UV treatment but was followed by a sustained rise in PtdBut accumulation between 4-12 hours (Fig. 4C) . Whilst the initial decline in phosphatidylcholine hydrolysis was also apparent in apoptosing cells expressing hPLD1b D545A , much of the second sustained phase of phosphatidylcholine hydrolysis observed between 4 and 12 hours was lost (Fig. 4C ). This data suggests that over-expression of a caspase-resistant form of PLD1b reduces the progress of phosphatidylcholine hydrolysis in apoptosing cells.
DISCUSSION
Both human PLD1b and PLD2a contain previously unrecognised caspase 3
cleavage sites not present in rat or mouse phospholipases D. In PLD2a, the caspase 3 site is located in the N-terminus at residue D 16 whereas in hPLD1b, the caspase 3 cleavage site is located in the loop region between the HKD motifs at residue D 549 .
The caspase motif identified in PLD1b (DEVD 545 S) is similar the classical caspase site identified in DNA topioisomerase I (DEVD) cytosolic PLA2 (DELD) and cleavage at this site is inhibited by the known peptide competitor DDVD [22, 38, 39] .
Structure and functional analysis has shown that PLD1b activity can be reconstituted when the ORF is separated (genetically) within the loop region and the two halves coexpressed within cells [40] . This observation has lead to the suggestion that interaction of the HKD motifs in the PLD domains, via folding of the loop region, is necessary for catalytic activity [1, 40] . Our data suggests that caspase-mediated cleavage of PLD1b could provide a post-translational mechanism that mimics this observation. Apoptosis involves a complex interplay of irreversible changes to the plasmamembrane, cytoskeleton and nucleus and our data suggest that PLD activity may either be targeted for destruction to facilitate these changes or through caspasemediated degradation become deregulated and therefore able to play a role in facilitating apoptotic changes. 
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